⌘K
Loading ticker…
As of 2026-08-24, Eastman Chemical Company (EMN) has a 3-month relative strength percentile of 44 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.7%, relative volume 0.74×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
EMN is in a stage 3 topping pattern, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 2.8% / 3.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
EMN is held by 42 ETFs as of May 2026. Top owner: VIOO at 0.51% weight, $30M notional. Top 3 carry $78M.
Held by 133 ETFs · $2.2B across latest filings · largest weight 10.89% (PSCM).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VIOOVanguard S&P Small-Cap 600 ETF | 0.51% | $30M | −0.04 pp |
| VAWVanguard Materials ETF | 0.56% | $25M | +0.03 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.16% | $23M | −0.01 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 1.01% | $19M | −0.10 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.06% |
| $16M |
| — |
| RWJ | 0.58% | $11M | −0.12 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.01% | $9M | — |
| VONVVanguard Russell 1000 Value ETF | 0.03% | $5M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $5M | — |
| AUSF | 0.52% | $4M | — |
Showing 10 of 42 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EMN Jan avg: 4.75% median: 8.43% win: 75% σ: 7.83% n: 4 2022-04-12 → 2026-07-31 | EMN Feb avg: 2.19% median: 1.60% win: 50% σ: 5.78% n: 4 2022-04-12 → 2026-07-31 | EMN Mar avg: 1.08% median: 0.03% win: 50% σ: 9.98% n: 4 2022-04-12 → 2026-07-31 | EMN Apr avg: -5.44% median: -4.50% win: 0% σ: 4.54% n: 5 2022-04-12 → 2026-07-31 | EMN May avg: 2.33% median: 3.80% win: 80% σ: 6.51% n: 5 2022-04-12 → 2026-07-31 | EMN Jun avg: -5.93% median: -4.73% win: 20% σ: 10.14% n: 5 2022-04-12 → 2026-07-31 | EMN Jul avg: 3.25% median: 4.43% win: 80% σ: 3.75% n: 5 2022-04-12 → 2026-07-31 | EMN Aug avg: -2.46% median: -2.03% win: 0% σ: 2.10% n: 4 2022-04-12 → 2026-07-31 (current) | EMN Sep avg: -8.17% median: -10.06% win: 25% σ: 12.96% n: 4 2022-04-12 → 2026-07-31 | EMN Oct avg: -1.55% median: -4.10% win: 25% σ: 6.63% n: 4 2022-04-12 → 2026-07-31 | EMN Nov avg: 7.22% median: 8.24% win: 75% σ: 6.36% n: 4 2022-04-12 → 2026-07-31 | EMN Dec avg: -2.20% median: -1.58% win: 50% σ: 8.93% n: 4 2022-04-12 → 2026-07-31 |